Biotech Bets: Astria, Avalo, and Gossamer's Risky Rewards
Update: 2025-10-11
Description
Biotech gambles! Discover three high-stakes companies—Astria, Avalo, and Gossamer Bio—chasing blockbuster drugs for rare diseases and lung conditions. Will their clinical trials deliver life-changing results and massive investor returns, or will they crash and burn? Tune in for a breakdown of potential payouts, timelines, and risks in this volatile sector.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
